Acrodermatitis enteropathica (AE) is a rare autosomal recessive disorder of zinc deficiency due to an abnormal intestinal zinc transporter. It is characterized by the triad of acral dermatitis, alopecia, and diarrhoea. Once AE is correctly diagnosed, patients are treated with orally administered zinc sulphate. In some patients, relapses occur during adolescence, despite the regular treatment. Here, we discuss the clinical and molecular features of a 13-year-old adolescent girl with acrodermatitis enteropathica who was resistant to high-dose zinc sulphate therapy. We successfully treated the patient with zinc gluconate and vitamin C, and we detected a novel homozygous c.541_551dup (p.Leu186fsX38) mutation in the exon 3 of her SLC39A4 gene.
CITATION STYLE
Kilic, M., Taskesen, M., Coskun, T., Gürakan, F., Tokatli, A., Sivri, H. S., … Küry, S. (2012). A zinc sulphate-resistant acrodermatitis enteropathica patient with a novel mutation in SLC39A4 gene. In JIMD Reports (Vol. 2, pp. 25–28). Springer. https://doi.org/10.1007/8904_2011_38
Mendeley helps you to discover research relevant for your work.